CPA
ABBV icon

Court Place Advisors’s AbbVie ABBV Stock Holding History

Court Place Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$3.38M Sell
14,578
-86
-0.6% -$17.5K 1.02% 25
2025
Q2 		$2.72M Sell
14,664
-155
-1% -$28.8K 0.86% 28
2025
Q1 		$3.1M Sell
14,819
-653
-4% -$127K 1.03% 25
2024
Q4 		$2.75M Sell
15,472
-2,023
-12% -$372K 0.89% 26
2024
Q3 		$3.45M Sell
17,495
-900
-5% -$168K 1.01% 24
2024
Q2 		$3.16M Sell
18,395
-751
-4% -$124K 0.99% 26
2024
Q1 		$3.49M Sell
19,146
-1,171
-6% -$202K 1.12% 24
2023
Q4 		$3.15M Hold
20,317
– – 1.03% 24
2023
Q3 		$3.03M Sell
20,317
-35
-0.2% -$5.14K 1.08% 23
2023
Q2 		$2.74M Sell
20,352
-543
-3% -$79.6K 0.96% 26
2023
Q1 		$3.33M Sell
20,895
-308
-1% -$47.1K 1.21% 21
2022
Q4 		$3.43M Sell
21,203
-100
-0.5% -$15.3K 1.24% 22
2022
Q3 		$2.86M Sell
21,303
-150
-0.7% -$21.5K 1.15% 24
2022
Q2 		$3.29M Hold
21,453
– – 1.24% 22
2022
Q1 		$3.48M Sell
21,453
-2,050
-9% -$298K 1.12% 23
2021
Q4 		$3.18M Hold
23,503
– – 0.88% 29
2021
Q3 		$2.54M Sell
23,503
-422
-2% -$48.2K 0.75% 37
2021
Q2 		$2.69M Buy
23,925
+200
+0.8% +$22.5K 0.79% 36
2021
Q1 		$2.57M Hold
23,725
– – 0.8% 36
2020
Q4 		$2.54M Sell
23,725
-322
-1% -$30.9K 0.85% 31
2020
Q3 		$2.11M Sell
24,047
-28
-0.1% -$2.64K 0.79% 34
2020
Q2 		$2.36M Buy
24,075
+1,107
+5% +$97.5K 0.92% 28
2020
Q1 		$1.75M Hold
22,968
– – 0.78% 35
2019
Q4 		$2.03M Sell
22,968
-130
-0.6% -$10.8K 0.73% 38
2019
Q3 		$1.75M Sell
23,098
-621
-3% -$42.6K 0.68% 40
2019
Q2 		$1.73M Buy
23,719
+595
+3% +$46.8K 0.68% 39
2019
Q1 		$1.86M Buy
23,124
+104
+0.5% +$8.51K 0.75% 36
2018
Q4 		$2.12M Buy
23,020
+3
+0% +$264 0.97% 31
2018
Q3 		$2.18M Sell
23,017
-153
-0.7% -$14.5K 0.83% 36
2018
Q2 		$2.15M Buy
23,170
+202
+0.9% +$19.7K 0.89% 37
2018
Q1 		$2.17M Buy
22,968
+552
+2% +$60.6K 0.91% 37
2017
Q4 		$2.17M Buy
22,416
+2
+0% +$188 0.9% 36
2017
Q3 		$1.99M Buy
22,414
+83
+0.4% +$6.32K 0.89% 36
2017
Q2 		$1.62M Buy
22,331
+1,850
+9% +$124K 0.77% 40
2017
Q1 		$1.33M Buy
20,481
+212
+1% +$13.3K 0.66% 43
2016
Q4 		$1.27M Buy
20,269
+3,468
+21% +$212K 0.66% 45
2016
Q3 		$1.06M Buy
16,801
+100
+0.6% +$6.47K 0.59% 47
2016
Q2 		$1.03M Buy
16,701
+3,883
+30% +$237K 0.6% 47
2016
Q1 		$732K Buy
12,818
+450
+4% +$25.1K 0.45% 54
2015
Q4 		$733K Buy
12,368
+693
+6% +$39.9K 0.47% 53
2015
Q3 		$635K Sell
11,675
-300
-3% -$19.5K 0.44% 56
2015
Q2 		$805K Sell
11,975
-50
-0.4% -$3.26K 0.51% 53
2015
Q1 		$704K Hold
12,025
– – 0.45% 55
2014
Q4 		$787K Sell
12,025
-160
-1% -$10.1K 0.51% 53
2014
Q3 		$704K Hold
12,185
– – 0.48% 54
2014
Q2 		$688K Buy
12,185
+2,050
+20% +$108K 0.48% 55
2014
Q1 		$521K Hold
10,135
– – 0.38% 64
2013
Q4 		$535K Buy
+10,135
New +$498K 0.41% 60

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Court Place Advisors's ABBV Position: Q3 2025 in Review

Court Place Advisors reduced its AbbVie (ABBV) stake by 0.59% in Q3 2025, selling an estimated $17.5K and leaving 14,578 shares worth $3.38M. The position accounts for 1.02% of the portfolio, ranked #25.

Court Place Advisors first reported a position in ABBV in Q4 2013 and has held it in 48 quarters since. The position peaked at $3.49M in Q1 2024. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Court Place Advisors held 14,578 shares of AbbVie worth $3.38M as of Q3 2025.
  • Court Place Advisors sold 86 AbbVie shares in Q3 2025, an estimated $17.5K.
  • AbbVie made up 1.02% of Court Place Advisors's portfolio in Q3 2025, its #25 holding.
  • Court Place Advisors first reported a position in AbbVie in Q4 2013 and has held it in 48 quarters since.
  • Court Place Advisors's AbbVie position peaked at $3.49M in Q1 2024.
  • 3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Court Place Advisors's 13F filing for Q3 2025, filed 25 Nov 2025.